|
14 Apr 2025 |
Indegene
|
Consensus Share Price Target
|
571.30 |
657.00 |
- |
15.00 |
hold
|
|
|
|
|
10 Jul 2024
|
Indegene
|
Monarch Networth Capital Limited
|
571.30
|
660.00
|
569.95
(0.24%)
|
Target met |
Buy
|
|
|
|
|
06 May 2024
|
Indegene
|
KRChoksey
|
571.30
|
|
|
|
IPO Subscribe
|
|
|
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. The Company has established client relationships with each of the 20 largest biopharmaceutical companies in the world.
|
|
03 May 2024
|
Indegene
|
HDFC Securities
|
571.30
|
|
|
|
IPO Note
|
|
|
IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products
|
|
03 May 2024
|
Indegene
|
Ventura
|
571.30
|
|
|
|
IPO Subscribe
|
|
|
|
|
03 May 2024
|
Indegene
|
Ashika Research
|
571.30
|
|
|
|
IPO Note
|
|
|
|
|
03 May 2024
|
Indegene
|
SBI Securities
|
571.30
|
|
|
|
IPO Subscribe
|
|
|
|
|
02 May 2024
|
Indegene
|
Hem Securities
|
571.30
|
|
|
|
IPO Subscribe
|
|
|
|